ImmunityBio
IBRX
IBRX
139 hedge funds and large institutions have $256M invested in ImmunityBio in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 43 increasing their positions, 42 reducing their positions, and 11 closing their positions.
Holders
139
Holders Change
+13
Holders Change %
+10.32%
% of All Funds
2.24%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
26
Increased
43
Reduced
42
Closed
11
Calls
$3.69M
Puts
$4.76M
Net Calls
-$1.07M
Net Calls Change
-$345K
Top Buyers
1 |
CH
1
CVI Holdings
Wilmington,
Delaware
|
$38.6M |
2 |
SSWM
2
Sheets Smith Wealth Management
Winston-Salem,
North Carolina
|
$7.83M |
3 |
3
Balyasny Asset Management
Chicago,
Illinois
|
$4.55M |
4 |
4
BlackRock
New York
|
$35.6M |
5 |
5
Goldman Sachs
New York
|
$5.84M |